Johnson & Johnson (JNJ) Holdings Lessened by LVW Advisors LLC
LVW Advisors LLC trimmed its holdings in Johnson & Johnson (NYSE:JNJ) by 4.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 26,212 shares of the company’s stock after selling 1,258 shares during the period. Johnson & Johnson comprises approximately 1.4% of LVW Advisors LLC’s holdings, making the stock its 17th largest holding. LVW Advisors LLC’s holdings in Johnson & Johnson were worth $3,408,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Harding Loevner LP bought a new stake in shares of Johnson & Johnson in the 2nd quarter valued at approximately $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in shares of Johnson & Johnson by 29.9% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after acquiring an additional 200 shares during the last quarter. IHT Wealth Management LLC increased its holdings in shares of Johnson & Johnson by 46.4% in the 2nd quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock valued at $122,000 after acquiring an additional 3,467 shares during the last quarter. Mountain Capital Investment Advisors Inc bought a new stake in shares of Johnson & Johnson in the 2nd quarter valued at approximately $124,000. Finally, Shine Investment Advisory Services Inc. bought a new stake in shares of Johnson & Johnson in the 2nd quarter valued at approximately $177,000. 66.38% of the stock is currently owned by institutional investors.
In other news, VP Paulus Stoffels sold 155,342 shares of the stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $129.86, for a total value of $20,172,712.12. Following the completion of the transaction, the vice president now owns 357,906 shares of the company’s stock, valued at $46,477,673.16. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.19% of the company’s stock.
Johnson & Johnson (JNJ) opened at $128.82 on Monday. The company has a market capitalization of $345,611.47, a price-to-earnings ratio of 17.65, a P/E/G ratio of 2.11 and a beta of 0.77. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.12 and a current ratio of 1.41. Johnson & Johnson has a 52 week low of $120.95 and a 52 week high of $148.32.
Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, January 23rd. The company reported $1.74 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.72 by $0.02. Johnson & Johnson had a return on equity of 29.00% and a net margin of 1.70%. The company had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.08 billion. During the same quarter in the prior year, the business posted $1.58 earnings per share. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. analysts anticipate that Johnson & Johnson will post 8.11 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Tuesday, February 27th will be paid a $0.84 dividend. The ex-dividend date is Monday, February 26th. This represents a $3.36 annualized dividend and a dividend yield of 2.61%. Johnson & Johnson’s payout ratio is 861.54%.
COPYRIGHT VIOLATION NOTICE: This story was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.dailypolitical.com/2018/03/05/johnson-johnson-jnj-holdings-lessened-by-lvw-advisors-llc.html.
Johnson & Johnson Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.